IONS: Ionis Pharmaceuticals Inc

IONS News

• 10:20 mRNA Biotechs Stocks: Long-Term Value Risks Abound
• 19:50 Ionis: Dawnzera Approval Kicks Off New Era For Strikingly Undervalued Pharma (NASDAQ:IONS)
• 15:21 What's Going On With Takeda Stock On Friday? - Takeda Pharmaceutical Co (NYSE:TAK)
• 12:27 Piper Sandler raises Ionis Pharmaceuticals stock price target on FDA approval
• 10:25 Wells Fargo raises Ionis Pharmaceuticals stock price target on HAE drug approval
• 19:17 Ionis Pharmaceuticals stock price target raised to $43 by Stifel on Dawnzera approval
• 18:24 Why Is Ionis Pharma Stock Gaining Thursday? - Ionis Pharmaceuticals (NASDAQ:IONS)
• 17:39 Ionis Pharmaceuticals stock steady as BMO maintains Market Perform rating
• 15:59 US FDA approves Ionis’ drug for rare genetic disorder
• 09:52 IONS Premarket Gains 2.4% After C-Suite Insider Sells $440K In Stock - Stifel Financial (NYSE:SF), Ionis Pharmaceuticals (NASDAQ:IONS)
• 14:23 Ionis Pharmaceuticals stock rating reiterated at Buy by Jefferies
• 02:34 Tracking Tweedy Browne Portfolio – Q2 2025 Update (NYSEARCA:COPY)
• 08:07 Cathie Wood’s ARK bolsters Exact Sciences, sheds DraftKings stock
• 07:14 Cathie Wood’s ARK buys AMD and Twist, sells Shopify and Roblox stock
• 15:29 Why Morgan Stanley Upgraded This Biotech Stock to a Buy
• 06:20 Tweedy, Browne Mutual Funds Q2 2025 Commentary
• 00:15 Cathie Wood’s ARK ETFs shuffle RBLX, COIN, and BMNR stocks
• 17:12 BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock
• 13:10 Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook
• 11:30 Ionis Pharmaceuticals stock price target raised to $65 from $50 at H.C. Wainwright
• 21:14 Morgan Stanley upgrades Ionis Pharmaceuticals stock rating on strong Tryngolza launch
• 20:42 Ionis Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:IONS)
• 20:42 Ionis Pharmaceuticals, Inc. (IONS) Q2 2025 Earnings Call Transcript
• 18:34 Why Ionis Pharmaceuticals Shares Are Up After Q2 Report - Ionis Pharmaceuticals (NASDAQ:IONS)